We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+0.51%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$11.2B
AUM Growth
-$244M
Cap. Flow
-$183M
Cap. Flow %
-1.64%
Top 10 Hldgs %
22.89%
Holding
2,613
New
177
Increased
266
Reduced
1,243
Closed
46

Sector Composition

Rank Sector Weight
1 Technology 21.19%
2 Financials 13.17%
3 Healthcare 12.67%
4 Consumer Discretionary 11.48%
5 Industrials 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
URG
2326
Ur-Energy
URG
$537M
$130K ﹤0.01%
+75,333
New +$101K
ABUS icon
2327
Arbutus Biopharma
ABUS
$908M
$129K ﹤0.01%
+30,042
New +$100K
ALGS icon
2328
Aligos Therapeutics
ALGS
$43.7M
$129K ﹤0.01%
332
INSG icon
2329
Inseego
INSG
$82.6M
$129K ﹤0.01%
1,934
-1,075
-36% -$89.9K
BYSI icon
2330
BeyondSpring
BYSI
$32.5M
$129K ﹤0.01%
+8,173
New +$147K
LOCO icon
2331
El Pollo Loco
LOCO
$463M
$128K ﹤0.01%
7,566
DNUT icon
2332
Krispy Kreme
DNUT
$573M
$128K ﹤0.01%
+9,122
New +$146K
SXC icon
2333
SunCoke Energy
SXC
$801M
$128K ﹤0.01%
20,308
-12,575
-38% -$86.4K
PTVE
2334
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
$127K ﹤0.01%
10,170
-7,610
-43% -$103K
CATO icon
2335
Cato Corp
CATO
$65.7M
$127K ﹤0.01%
7,694
RFL icon
2336
Rafael Holdings
RFL
$103M
$127K ﹤0.01%
4,185
RES icon
2337
RPC Inc
RES
$1.4B
$127K ﹤0.01%
26,045
KNSA icon
2338
Kiniksa Pharmaceuticals
KNSA
$6.1B
$126K ﹤0.01%
11,087
WTI icon
2339
W&T Offshore
WTI
$555M
$126K ﹤0.01%
33,784
+18,891
+127% +$67.5K
BASE
2340
DELISTED
Couchbase
BASE
$126K ﹤0.01%
+4,038
New +$149K
CTSO icon
2341
Cytosorbents Corp
CTSO
$23.3M
$125K ﹤0.01%
+15,424
New +$125K
BDSI
2342
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$125K ﹤0.01%
34,579
+26,128
+309% +$98.6K
IPSC icon
2343
Century Therapeutics
IPSC
$355M
$124K ﹤0.01%
+4,939
New +$134K
QTTB icon
2344
Q32 Bio
QTTB
$458M
$124K ﹤0.01%
+874
New +$111K
URGN icon
2345
UroGen Pharma
URGN
$2.39B
$124K ﹤0.01%
+7,354
New +$117K
LXRX icon
2346
Lexicon Pharmaceuticals
LXRX
$1.05B
$123K ﹤0.01%
+25,604
New +$105K
XONE
2347
DELISTED
The ExOne Company
XONE
$123K ﹤0.01%
5,260
EWCZ
2348
DELISTED
European Wax Center
EWCZ
$123K ﹤0.01%
+4,374
New +$109K
ANIP icon
2349
ANI Pharmaceuticals
ANIP
$1.73B
$122K ﹤0.01%
+3,731
New +$116K
SYRE icon
2350
Spyre Therapeutics
SYRE
$9.18B
$122K ﹤0.01%
+614
New +$107K

Similar funds

MetLife Investment Management's Q3 2021 Portfolio in Review

As of Q3 2021, MetLife Investment Management held 2,613 positions worth $11.2B, down 2.1% from $11.4B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

MetLife Investment Management's Q3 2021 filing shows 177 new, 266 increased, 1,243 reduced and 46 closed positions. Its largest new stake was Moderna: 79,316 shares worth $30.5M. The largest sale was Energy Transfer Partners, an estimated $35.7M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q3 2021 buy was Moderna: 79,316 shares worth $30.5M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $39.7M increase.
  • MetLife Investment Management's biggest Q3 2021 reduction was Energy Transfer Partners, cutting an estimated $35.7M.
  • MetLife Investment Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $9.28M.
  • MetLife Investment Management's ten largest holdings make up 23% of its $11.2B portfolio in Q3 2021.
  • MetLife Investment Management opened 177 new positions and closed 46 in Q3 2021.
  • MetLife Investment Management's portfolio value fell 2.1% quarter-over-quarter to $11.2B.

Based on MetLife Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.